We are live on
!
Find out more
KIA
Kopp Investment Advisors Portfolio holdings
AUM
$54.4M
1-Year Est. Return
14.33%
This Fund
S&P 500
This Quarter
Est. Return
+8.41%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$256M
AUM Growth
–
Cap. Flow
+$249M
Cap. Flow
% of AUM
97.24%
Top 10 Holdings %
Top 10 Hldgs %
46.55%
Holding
93
New
93
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
+$19.3M |
| 2 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
+$16.6M |
| 3 |
FNSR
Finisar Corp
FNSR
|
+$15.2M |
| 4 |
AKRX
Akorn Inc
AKRX
|
+$12.6M |
| 5 |
EMKR
Emcore Corp
EMKR
|
+$10.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.52% |
| 2 | Technology | 25.75% |
| 3 | Miscellaneous | 16.74% |
| 4 | Consumer Staples | 4.53% |
| 5 | Financials | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IDTI
26
DELISTED
Integrated Device Technology I
IDTI
| $2.29M | 0.9% |
+288,682
| New | +$2.22M |
|
|
VVUS
27
DELISTED
Vivus Inc
VVUS
| $2.29M | 0.89% |
+18,194
| New | +$2.35M |
|
28
AngioDynamics
ANGO
$652M
| $2.13M | 0.83% |
+189,116
| New | +$2.01M |
|
29
Celldex Therapeutics
CLDX
$3.18B
| $2.11M | 0.82% |
+8,994
| New | +$1.77M |
|
|
ACCL
30
DELISTED
Accelrys Inc
ACCL
| $2.06M | 0.81% |
+245,645
| New | +$2.18M |
|
31
Ligand Pharmaceuticals
LGND
$5.67B
| $1.85M | 0.72% |
+79,155
| New | +$1.42M |
|
|
CTCT
32
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $1.83M | 0.72% |
+114,021
| New | +$1.65M |
|
|
NVDQ
33
DELISTED
Novadaq Technologies Inc.
NVDQ
| $1.83M | 0.71% |
+135,682
| New | +$1.74M |
|
|
IL
34
DELISTED
IntraLinks Holdings Inc.
IL
| $1.69M | 0.66% |
+232,199
| New | +$1.42M |
|
|
TQNT
35
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
| $1.38M | 0.54% |
+199,593
| New | +$1.21M |
|
|
CPHD
36
DELISTED
Cepheid Inc
CPHD
| $1.35M | 0.53% |
+39,368
| New | +$1.44M |
|
37
Regeneron Pharmaceuticals
REGN
$83.2B
| $1.34M | 0.52% |
+5,963
| New | +$1.39M |
|
|
THOR
38
DELISTED
THORATEC CORPORATION
THOR
| $1.33M | 0.52% |
+42,495
| New | +$1.43M |
|
|
LCI
39
DELISTED
Lannett Company, Inc.
LCI
| $1.28M | 0.5% |
+26,915
| New | +$1.22M |
|
40
HealthStream
HSTM
$843M
| $1.25M | 0.49% |
+49,378
| New | +$1.19M |
|
|
OREX
41
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.25M | 0.49% |
+21,375
| New | +$1.31M |
|
42
Cytokinetics
CYTK
$10.8B
| $1.24M | 0.49% |
+107,343
| New | +$846K |
|
|
ROCM
43
DELISTED
ROCHESTER MEDICAL CORP
ROCM
| $1.23M | 0.48% |
+83,268
| New | +$1.19M |
|
44
Alkermes
ALKS
$8.2B
| $1.21M | 0.47% |
+42,034
| New | +$1.23M |
|
45
Johnson & Johnson
JNJ
$640B
| $1.08M | 0.42% |
+12,563
| New | +$1.07M |
|
46
Neogen
NEOG
$2.56B
| $1.07M | 0.42% |
+77,240
| New | +$1.02M |
|
|
RKUS
47
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $1.01M | 0.39% |
+78,597
| New | +$1.16M |
|
|
GNMK
48
DELISTED
GenMark Diagnostics, Inc
GNMK
| $997K | 0.39% |
+96,384
| New | +$1.33M |
|
49
Blackrock
BLK
$181B
| $981K | 0.38% |
+3,820
| New | +$1.02M |
|
50
Wells Fargo
WFC
$257B
| $980K | 0.38% |
+23,748
| New | +$925K |
|
Similar funds
OPPM
GX
PGA
SCG
TCMV
FCM
SAM
ACP
Kopp Investment Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Kopp Investment Advisors, which disclosed 93 positions worth $256M. Its ten largest holdings account for 47% of the portfolio.
Its largest position is Array Biopharma Inc: 3,587,128 shares worth $16.3M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, followed by Technology and Miscellaneous.
- Kopp Investment Advisors's largest Q2 2013 buy was Array Biopharma Inc: 3,587,128 shares worth $16.3M.
- Kopp Investment Advisors's ten largest holdings make up 47% of its $256M portfolio in Q2 2013.
- Kopp Investment Advisors disclosed 93 positions in Q2 2013, its first 13F filing on record.
Based on Kopp Investment Advisors's 13F filing for Q2 2013, filed 5 Aug 2013.